Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

June 14, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

September 30, 2024

Conditions
Osteoarthritis
Interventions
DEVICE

SP5M002 inj

pre-filled syringe

DEVICE

Synovian inj

pre-filled syringe

Trial Locations (16)

Unknown

Kyungpook National University Hospital, Daegu

Yeungnam University Medical Center, Daegu

Chonnam National University Bitgoeul Hospital, Gwangju

Gachon University Gil Medical Center, Incheon

Jeonbuk National University Hospital, Jeonju

Gyeongsang National University Hospital, Jinju

Chungnam National University Hospital, Sejong

CHA University Bundang Medical Center, Seongnam

EWHA Womans University Mokdong Hospital, Seoul

Gangnam Severance Hospita, Seoul

Kyung Hee University Hospital at Gangdong, Seoul

Kyunghee University Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Boramae Medical Center, Seoul

Seoul National University Hospital, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
lead

Shin Poong Pharmaceutical Co. Ltd.

INDUSTRY